These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 18261820)
1. RNase H activity: structure, specificity, and function in reverse transcription. Schultz SJ; Champoux JJ Virus Res; 2008 Jun; 134(1-2):86-103. PubMed ID: 18261820 [TBL] [Abstract][Full Text] [Related]
2. Multiple nucleotide preferences determine cleavage-site recognition by the HIV-1 and M-MuLV RNases H. Schultz SJ; Zhang M; Champoux JJ J Mol Biol; 2010 Mar; 397(1):161-78. PubMed ID: 20122939 [TBL] [Abstract][Full Text] [Related]
3. Preferred sequences within a defined cleavage window specify DNA 3' end-directed cleavages by retroviral RNases H. Schultz SJ; Zhang M; Champoux JJ J Biol Chem; 2009 Nov; 284(47):32225-38. PubMed ID: 19778906 [TBL] [Abstract][Full Text] [Related]
4. Mutations of the RNase H C helix of the Moloney murine leukemia virus reverse transcriptase reveal defects in polypurine tract recognition. Lim D; Orlova M; Goff SP J Virol; 2002 Aug; 76(16):8360-73. PubMed ID: 12134040 [TBL] [Abstract][Full Text] [Related]
5. Analysis of plus-strand primer selection, removal, and reutilization by retroviral reverse transcriptases. Schultz SJ; Zhang M; Kelleher CD; Champoux JJ J Biol Chem; 2000 Oct; 275(41):32299-309. PubMed ID: 10913435 [TBL] [Abstract][Full Text] [Related]
6. Structural and inhibition studies of the RNase H function of xenotropic murine leukemia virus-related virus reverse transcriptase. Kirby KA; Marchand B; Ong YT; Ndongwe TP; Hachiya A; Michailidis E; Leslie MD; Sietsema DV; Fetterly TL; Dorst CA; Singh K; Wang Z; Parniak MA; Sarafianos SG Antimicrob Agents Chemother; 2012 Apr; 56(4):2048-61. PubMed ID: 22252812 [TBL] [Abstract][Full Text] [Related]
7. Recognition of internal cleavage sites by retroviral RNases H. Schultz SJ; Zhang M; Champoux JJ J Mol Biol; 2004 Nov; 344(3):635-52. PubMed ID: 15533434 [TBL] [Abstract][Full Text] [Related]
8. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase. Gao HQ; Sarafianos SG; Arnold E; Hughes SH J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369 [TBL] [Abstract][Full Text] [Related]
9. Sequence, distance, and accessibility are determinants of 5'-end-directed cleavages by retroviral RNases H. Schultz SJ; Zhang M; Champoux JJ J Biol Chem; 2006 Jan; 281(4):1943-55. PubMed ID: 16306040 [TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of the RNase H domain of Moloney murine leukemia virus reverse transcriptase. Nishimura K; Yokokawa K; Hisayoshi T; Fukatsu K; Kuze I; Konishi A; Mikami B; Kojima K; Yasukawa K Protein Expr Purif; 2015 Sep; 113():44-50. PubMed ID: 25959458 [TBL] [Abstract][Full Text] [Related]
11. Construction of an enzymatically active ribonuclease H domain of human immunodeficiency virus type 1 reverse transcriptase. Stahl SJ; Kaufman JD; Vikić-Topić S; Crouch RJ; Wingfield PT Protein Eng; 1994 Sep; 7(9):1103-8. PubMed ID: 7530360 [TBL] [Abstract][Full Text] [Related]
12. Polypurine tract primer generation and utilization by Moloney murine leukemia virus reverse transcriptase. Schultz SJ; Zhang M; Kelleher CD; Champoux JJ J Biol Chem; 1999 Dec; 274(49):34547-55. PubMed ID: 10574917 [TBL] [Abstract][Full Text] [Related]
13. RNase H cleavage of tRNAPro mediated by M-MuLV and HIV-1 reverse transcriptases. Smith CM; Potts WB; Smith JS; Roth MJ Virology; 1997 Mar; 229(2):437-46. PubMed ID: 9126256 [TBL] [Abstract][Full Text] [Related]
14. Specificity of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H in removal of the minus-strand primer, tRNA(Lys3). Smith JS; Roth MJ J Biol Chem; 1992 Jul; 267(21):15071-9. PubMed ID: 1378844 [TBL] [Abstract][Full Text] [Related]
16. RNase H domain of Moloney murine leukemia virus reverse transcriptase retains activity but requires the polymerase domain for specificity. Schultz SJ; Champoux JJ J Virol; 1996 Dec; 70(12):8630-8. PubMed ID: 8970988 [TBL] [Abstract][Full Text] [Related]
17. RNase H activity of reverse transcriptases on substrates derived from the 5' end of retroviral genome. Ben-Artzi H; Zeelon E; Amit B; Wortzel A; Gorecki M; Panet A J Biol Chem; 1993 Aug; 268(22):16465-71. PubMed ID: 7688365 [TBL] [Abstract][Full Text] [Related]
18. Amino acid substitutions away from the RNase H catalytic site increase the thermal stability of Moloney murine leukemia virus reverse transcriptase through RNase H inactivation. Konishi A; Hisayoshi T; Yokokawa K; Barrioluengo V; Menéndez-Arias L; Yasukawa K Biochem Biophys Res Commun; 2014 Nov; 454(2):269-74. PubMed ID: 25450388 [TBL] [Abstract][Full Text] [Related]
19. Specific cleavages by RNase H facilitate initiation of plus-strand RNA synthesis by Moloney murine leukemia virus. Schultz SJ; Zhang M; Champoux JJ J Virol; 2003 May; 77(9):5275-85. PubMed ID: 12692229 [TBL] [Abstract][Full Text] [Related]
20. Cleavage specificities of Moloney murine leukemia virus RNase H implicated in the second strand transfer during reverse transcription. Schultz SJ; Whiting SH; Champoux JJ J Biol Chem; 1995 Oct; 270(41):24135-45. PubMed ID: 7592616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]